The Health Innovation, Investment and Research Office (HIIRO), within the Office of the Director-General, aims to improve the health and wellbeing of Queenslanders through a coordinated and collaborative approach to health innovation, investment and research.
HIIRO provides a strategic framework for research, investment and innovation activities to ensure Queensland Health is positioned to meet the state’s current and future healthcare needs, create and maintain jobs, boost the state’s economy and improve patient outcomes.
HIIRO focuses on three priority areas to strengthen Queensland’s approach to health and medical research and innovation by:
Trade and investment
- harnessing and developing capabilities in Queensland’s health sector, attracting investment and promoting health services and product exports, in partnership with Queensland’s Department of State Development, Manufacturing, Infrastructure and Planning, Department of Environment and Science, and Trade and Investment Queensland
- initiating international engagement programs for Queensland’s health sector which enable export and investment activities.
- managing research grants and fellowships that leverage co-investment and build individual and institutional capacity to address priority health issues for Queenslanders
- promoting the translation of research into improved practice and technologies at scale, including through clinical trials and commercialisation.
Clinical trials, research ethics and governance
- providing a central point of contact for researchers, research managers and study sponsors seeking advice and direction on ethical and governance issues associated with research and clinical trials
- managing a robust research ethics and governance framework that ensures patient safety, while streamlining administrative and regulatory burdens.